Postherpetic neuralgia: epidemiology, pathophysiology and management

References

• Lydick E, Epstein RS, Himmelberger D, White CJ. Herpes zoster and quality of life: a self-limited disease with severe impact. Neurology45(12 Suppl. 8), S52–S53 (1995).
   PubMed Web of Science ®Google Scholar
• Wood MJ, Kay R, Dworkin RH, Soong SJ, Whitley RJ. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clin. Infect. Dis.22(2), 341–347 (1996).
   PubMed Web of Science ®Google Scholar
• Lancaster T, Silagy S, Gray S. Primary care management of acute herpes zoster: systematic review of evidence from randomized controlled trials. Br. J. Gen. Pract.45, 39–45 (1995).
   PubMed Web of Science ®Google Scholar
• Jackson JL, Gibbons R, Meyer G, Inouye L. The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia. A meta-analysis. Arch. Intern. Med.157(8), 909–912 (1997).
   PubMed Web of Science ®Google Scholar
• Alper BS, Lewis PR. Does treatment of acute herpes zoster prevent or shorten postherpetic neuralgia? J. Fam. Pract.49(3), 255–264 (2000).
   PubMed Web of Science ®Google Scholar
• Oxman MN, Levin MJ, Johnson GR et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N. Engl. J. Med.352(22), 2271–2284 (2005).
   PubMed Web of Science ®Google Scholar
• Johnson R, Whitley R. Guidelines on varicella zoster virus. Herpes13(Suppl. 1), 3–41 (2006).
   PubMedGoogle Scholar
• Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain118(3), 289–305 (2005).
   PubMed Web of Science ®Google Scholar
• Hempenstall K, Nurmikko TJ, Johnson RW, A’Hern RP, Rice AS. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med.2(7), E164 (2005).
   PubMed Web of Science ®Google Scholar
• Dworkin RH, Johnson RW, Breuer J et al. Recommendations for the management of herpes zoster. Clin. Infect. Dis.44(Suppl. 1), S1–26 (2007).
   PubMed Web of Science ®Google Scholar
• Johnson R. Patient awareness of herpes zoster: the global herpes zoster survey – a preliminary report. Herpes13(Suppl. 1), 40–41 (2006).
   Google Scholar
• Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc. R. Soc. Med.58, 9–20 (1965).
   PubMedGoogle Scholar
• Ragozzino MW, Melton LJ III, Kurland LT, Chu CP, Perry HO. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore)61(5), 310–316 (1982).
   PubMed Web of Science ®Google Scholar
• Burgoon CF, Burgoon JS, Baldridge GD. The natural history of herpes zoster. JAMA164(3), 265–269 (1957).
   PubMed Web of Science ®Google Scholar
• Scott FT, Johnson RW, Leedham-Green M, Davies E, Edmunds WJ, Breuer J. The burden of herpes zoster: a prospective population based study. Vaccine24(9), 1308–1314 (2006).
   PubMed Web of Science ®Google Scholar
• Bowsher D. Postherpetic neuralgia and its treatment: a retrospective survey of 191 patients. J. Pain Symptom Manage.12(5), 290–299 (1996).
   PubMed Web of Science ®Google Scholar
• Hope-Simpson RE. Postherpetic neuralgia. J. R. Coll. Gen. Pract.25(157), 571–575 (1975).
   PubMedGoogle Scholar
• de Moragas M, Kierland RR. The outcome of patients with herpes zoster. Arch. Derm.75, 193–196 (1957).
   Web of Science ®Google Scholar
• Opstelten W, Van Essen GA, Schellevis F, Verheij TJ, Moons K. Gender as an independent risk factor for herpes zoster: a population-based prospective study. Ann. Epidemiol.16(9), 692–695 (2006).
   PubMed Web of Science ®Google Scholar
• Jung BF, Johnson RW, Griffin DR, Dworkin RH. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology62(9), 1545–1551 (2004).
   PubMed Web of Science ®Google Scholar
• Nagasako EM, Johnson RW, Griffin DR, Dworkin RH. Rash severity in herpes zoster: correlates and relationship to postherpetic neuralgia. J. Am. Acad. Dermatol.46(6), 834–839 (2002).
   PubMed Web of Science ®Google Scholar
• Higa K. Acute herpetic pain and post-herpetic neuralgia. Eur. J. Pain14(4), 79–90 (1993).
   Google Scholar
• Haanpaa M, Laippala P, Nurmikko T. Allodynia and pinprick hypesthesia in acute herpes zoster, and the development of postherpetic neuralgia. J. Pain Symptom Manage.20(1), 50–58 (2000).
   PubMed Web of Science ®Google Scholar
• Rice AS, Maton S. Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain94(2), 215–224 (2001).
   PubMed Web of Science ®Google Scholar
• Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA280(21), 1837–1842 (1998).
   PubMed Web of Science ®Google Scholar
• Sang CN, Booher S, Gilron I, Parada S, Max MB. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials. Anesthesiology96(5), 1053–1061 (2002).
   PubMed Web of Science ®Google Scholar
• Johnson RW, Rice AS. Pain following herpes zoster: the influence of changing population characteristics and medical developments. Pain128(1–2), 3–5 (2007).
   PubMed Web of Science ®Google Scholar
• Dworkin RH. Inadequate evidence for a revised definition of postherpetic neuralgia (PHN). Pain128(1–2), 189–190; author reply 190–182 (2007).
   PubMed Web of Science ®Google Scholar
• Cunningham AL, Dworkin RH. The management of post-herpetic neuralgia. Br. Med. J.321(7264), 778–779 (2000).
   PubMed Web of Science ®Google Scholar
• Dworkin RH, Carrington D, Cunningham A et al. Assessment of pain in herpes zoster: lessons learned from antiviral trials. Antiviral Res.33(2), 73–85 (1997).
   PubMed Web of Science ®Google Scholar
• Gnann JW Jr, Whitley RJ. Clinical practice. Herpes zoster. N. Engl. J. Med.347(5), 340–346 (2002).
   PubMed Web of Science ®Google Scholar
• Schmader K. Herpes zoster in older adults. Clin. Infect. Dis.32(10), 1481–1486 (2001).
   PubMed Web of Science ®Google Scholar
• Straus SE, Ostrove JM, Inchauspe G et al. NIH conference. Varicella – zoster virus infections. Biology, natural history, treatment, and prevention. Ann. Intern. Med.108(2), 221–237 (1988).
   PubMed Web of Science ®Google Scholar
• Brisson M, Edmunds WJ. Epidemiology of varicella-zoster virus in England and Wales. J. Med. Virol.70(Suppl. 1), S9–S14 (2003).
   PubMedGoogle Scholar
• Opstelten W, Mauritz JW, de Wit NJ, van Wijck AJ, Stalman WA, van Essen GA. Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Fam. Pract.19(5), 471–475 (2002).
   PubMed Web of Science ®Google Scholar
• di Luzio Paparatti U, Arpinelli F, Visona G. Herpes zoster and its complications in Italy: an observational survey. J. Infect.38(2), 116–120 (1999).
   PubMed Web of Science ®Google Scholar
• Law B, Chateau D, Walld R, Roos L. Temporal trends in the annual population-based incidence of herpes zoster by age and gender. Manitoba, 1979–1998. Presented at: 6th Canadian Immunization Conference. Quebec, Canada, 5–8 December 2004.
   Google Scholar
• Chidiac C, Bruxelle J, Daures JP et al. Characteristics of patients with herpes zoster on presentation to practitioners in France. Clin. Infect. Dis.33(1), 62–69 (2001).
   PubMed Web of Science ®Google Scholar
• Donahue JG, Choo PW, Manson JE, Platt R. The incidence of herpes zoster. Arch. Intern. Med.155(15), 1605–1609 (1995).
   PubMed Web of Science ®Google Scholar
• Czernichow S, Dupuy A, Flahault A, Chosidow O. Herpes zoster:incidence study among “sentinel” general practitioners. Ann. Dermatol. Venereol.128(4), 497–501 (2001).
   PubMed Web of Science ®Google Scholar
• Insinga RP, Itzler RF, Pellissier JM, Saddier P, Nikas AA. The incidence of herpes zoster in a United States administrative database. J. Gen. Intern. Med.20(8), 748–753 (2005).
   PubMed Web of Science ®Google Scholar
• Brisson M, Edmunds WJ, Law B et al. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol. Infect.127(2), 305–314 (2001).
   PubMed Web of Science ®Google Scholar
• Brisson M, Edmunds WJ, Gay NJ. Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV. J. Med. Virol.70(Suppl. 1), S31–S37 (2003).
   PubMed Web of Science ®Google Scholar
• Bowsher D. The lifetime occurrence of herpes zoster and prevalence of post-herpetic neuralgia: a retrospective survey in an elderly population. Eur. J. Pain3(4), 335–342 (1999).
   PubMed Web of Science ®Google Scholar
• Helgason S, Sigurdsson J, Gudmundsson S. The clinical course of herpes zoster: a prospective study in primary care. Eur. J. Gen. Pract.2, 12–15 (1996).
   Google Scholar
• Watson CP, Watt VR, Chipman M, Birkett N, Evans RJ. The prognosis with postherpetic neuralgia. Pain46(2), 195–199 (1991).
   PubMed Web of Science ®Google Scholar
• Kost RG, Straus SE. Postherpetic neuralgia – pathogenesis, treatment, and prevention. N. Engl. J. Med.335(1), 32–42 (1996).
   PubMed Web of Science ®Google Scholar
• Crooks RJ, Jones DA, Fiddian AP. Zoster-associated chronic pain: an overview of clinical trials with acyclovir. Scand. J. Infect. Dis. (Suppl. 80), 62–68 (1991).
   Google Scholar
• Goh CL, Khoo L. A retrospective study of the clinical presentation and outcome of herpes zoster in a tertiary dermatology outpatient referral clinic. Int. J. Dermatol.36(9), 667–672 (1997).
   PubMed Web of Science ®Google Scholar
• Katz J, Cooper EM, Walther RR, Sweeney EW, Dworkin RH. Acute pain in herpes zoster and its impact on health-related quality of life. Clin. Infect. Dis.39(3), 342–348 (2004).
   PubMed Web of Science ®Google Scholar
• Schmader KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin. J. Pain18(6), 350–354 (2002).
   PubMed Web of Science ®Google Scholar
• Oster G, Harding G, Dukes E, Edelsberg J, Cleary PD. Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey. J. Pain6(6), 356–363 (2005).
   PubMed Web of Science ®Google Scholar
• MacIntyre CR, Chu CP, Burgess MA. Use of hospitalization and pharmaceutical prescribing data to compare the prevaccination burden of varicella and herpes zoster in Australia. Epidemiol. Infect.131(1), 675–682 (2003).
   PubMed Web of Science ®Google Scholar
• Saddier P, Sy L, Nikas A et al. Herpes zoster hospitalizations in the United States, 1998–2002. Presented at: 44th Annual Meeting of Infectious Disease Society of America (IDSA). Toronto, Canada, 12–15 October 2006.
   Google Scholar
• Brisson M. Modeling the burden of herpes zoster (HZ) and postherpetic neuralgia (PHN) in Canada. Presented at: 6th Canadian Immunization Conference. Montreal, Quebec, Canada, 5–8 December 2004.
   Google Scholar
• Gil A, San-Martin M, Carrasco P, Gonzalez A. Epidemiology of severe varicella-zoster virus infection in Spain. Vaccine22(29–30), 3947–3951 (2004).
   PubMed Web of Science ®Google Scholar
• Lin F, Hadler JL. Epidemiology of primary varicella and herpes zoster hospitalizations: the pre-varicella vaccine era. J. Infect. Dis.181(6), 1897–1905 (2000).
   PubMed Web of Science ®Google Scholar
• Brisson M, Edmunds WJ. Varicella vaccination in England and Wales: cost-utility analysis. Arch. Dis. Child.88(10), 862–869 (2003).
   PubMed Web of Science ®Google Scholar
• Omana-Zapata I, Khabbaz MA, Hunter JC, Clarke DE, Bley KR. Tetrodotoxin inhibits neuropathic ectopic activity in neuromas, dorsal root ganglia and dorsal horn neurons. Pain72(1–2), 41–49 (1997).
   PubMed Web of Science ®Google Scholar
• Garry EM, Delaney A, Anderson HA et al. Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioral reflex sensitisation that is attenuated by gabapentin or sodium channel blocking drugs. Pain118(1–2), 97–111 (2005).
   PubMed Web of Science ®Google Scholar
• Rowbotham MC, Yosipovitch G, Connolly MK, Finlay D, Forde G, Fields HL. Cutaneous innervation density in the allodynic form of postherpetic neuralgia. Neurobiol. Dis.3(3), 205–214 (1996).
   PubMed Web of Science ®Google Scholar
• Pappagallo M, Oaklander AL, Quatrano-Piacentini AL, Clark MR, Raja SN. Heterogenous patterns of sensory dysfunction in postherpetic neuralgia suggest multiple pathophysiologic mechanisms. Anesthesiology92(3), 691–698 (2000).
   PubMed Web of Science ®Google Scholar
• Petersen KL, Fields HL, Brennum J, Sandroni P, Rowbotham MC. Capsaicin evoked pain and allodynia in post-herpetic neuralgia. Pain88(2), 125–133 (2000).
   PubMed Web of Science ®Google Scholar
• Baron R, Schwarz K, Kleinert A, Schattschneider J, Wasner G. Histamine-induced itch converts into pain in neuropathic hyperalgesia. Neuroreport12(16), 3475–3478 (2001).
   PubMed Web of Science ®Google Scholar
• Tal M, Bennett GJ. Extra-territorial pain in rats with a peripheral mononeuropathy: mechano-hyperalgesia and mechano-allodynia in the territory of an uninjured nerve. Pain57(3), 375–382 (1994).
   PubMed Web of Science ®Google Scholar
• Baron R, Saguer M. Postherpetic neuralgia. Are C-nociceptors involved in signalling and maintenance of tactile allodynia? Brain116(Pt 6), 1477–1496 (1993).
   PubMed Web of Science ®Google Scholar
• Price DD, Long S, Huitt C. Sensory testing of pathophysiological mechanisms of pain in patients with reflex sympathetic dystrophy. Pain49(2), 163–173 (1992).
   PubMed Web of Science ®Google Scholar
• Fields HL, Rowbotham M, Baron R. Postherpetic neuralgia: irritable nociceptors and deafferentation. Neurobiol. Dis.5(4), 209–227 (1998).
   PubMed Web of Science ®Google Scholar
• Wasner G, Kleinert A, Binder A, Schattschneider J, Baron R. Postherpetic neuralgia: topical lidocaine is effective in nociceptor-deprived skin. J. Neurol.252(6), 677–686 (2005).
   PubMed Web of Science ®Google Scholar
• Oaklander AL. The density of remaining nerve endings in human skin with and without postherpetic neuralgia after shingles. Pain92(1–2), 139–145 (2001).
   PubMed Web of Science ®Google Scholar
• Oaklander AL, Romans K, Horasek S, Stocks A, Hauer P, Meyer RA. Unilateral postherpetic neuralgia is associated with bilateral sensory neuron damage. Ann. Neurol.44(5), 789–795 (1998).
   PubMed Web of Science ®Google Scholar
• Baron R, Saguer M. Axon-reflex reactions in affected and homologous contralateral skin after unilateral peripheral injury of thoracic segmental nerves in humans. Neurosci. Lett.165(1–2), 97–100 (1994).
   PubMed Web of Science ®Google Scholar
• Choi B, Rowbotham MC. Effect of adrenergic receptor activation on post-herpetic neuralgia pain and sensory disturbances. Pain69(1–2), 55–63 (1997).
   PubMed Web of Science ®Google Scholar
• Nurmikko T, Bowsher D. Somatosensory findings in postherpetic neuralgia. J. Neurol. Neurosurg. Psychiatry53(2), 135–141 (1990).
   PubMed Web of Science ®Google Scholar
• Nurmikko T, Wells C, Bowsher D. Sensory dysfunction in postherpetic neuralgia. In: Touch, Temperature, and Pain in Health and Disease: Mechanisms and Assessments. Boivie J, Hanson P, Lindblom U (Eds). IASP Press, Seattle, WA, USA 133–141 (1994).
   Google Scholar
• Lombard M, Larabi Y. Electrophysiological study of cervical dorsal horn cells in partially deafferented rats. In: Advances in Pain Research and Therapy. Bonica J (Ed.). Raven Press, New York, USA 147–154 (1983).
   Google Scholar
• Watson CPN, Deck JH, Morshead C, Van der Kooy D, Evans RJ. Post-herpetic neuralgia: further post-mortem studies of cases with and without pain. Pain44, 105–117 (1991).
   PubMed Web of Science ®Google Scholar
• Gilden DH, Dueland AN, Cohrs R, Martin JR, Kleinschmidt-DeMasters BK, Mahalingam R. Preherpetic neuralgia. Neurology41(8), 1215–1218 (1991).
   PubMed Web of Science ®Google Scholar
• Herrmann DN, Pannoni V, Barbano RL, Pennella-Vaughan J, Dworkin RH. Skin biopsy and quantitative sensory testing do not predict response to lidocaine patch in painful neuropathies. Muscle Nerve33(1), 42–48 (2006).
   PubMed Web of Science ®Google Scholar
• Thomas SL, Wheeler JG, Hall AJ. Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet360(9334), 678–682 (2002).
   PubMed Web of Science ®Google Scholar
• Edmunds WJ, Brisson M. The effect of vaccination on the epidemiology of varicella zoster virus. J. Infect.44(4), 211–219 (2002).
   PubMed Web of Science ®Google Scholar
• Wassilew S. Brivudin compared with famciclovir in the treatment of herpes zoster: effects in acute disease and chronic pain in immunocompetent patients. A randomized, double-blind, multinational study. J. Eur. Acad. Dermatol. Venereol.19(1), 47–55 (2005).
   PubMed Web of Science ®Google Scholar
• Wood MJ, Johnson RW, McKendrick MW, Taylor J, Mandal BK, Crooks J. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N. Engl. J. Med.330(13), 896–900 (1994).
   PubMed Web of Science ®Google Scholar
• Whitley RJ, Weiss H, Gnann J et al. The efficacy of steroids and acyclovir therapy of herpes zoster in the elderly. Antiviral Res.26, A303 (1995).
   Google Scholar
• Bowsher D. The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trial. J. Pain Symptom Manage.13(6), 327–331 (1997).
   PubMed Web of Science ®Google Scholar
• Kuraishi Y, Takasaki I, Nojima H, Shiraki K, Takahata H. Effects of the suppression of acute herpetic pain by gabapentin and amitriptyline on the incidence of delayed postherpetic pain in mice. Life Sci.74(21), 2619–2626 (2004).
   PubMed Web of Science ®Google Scholar
• van Wijck AJ, Opstelten W, Moons KG et al. The PINE study of epidural steroids and local anaesthetics to prevent postherpetic neuralgia: a randomised controlled trial. Lancet367(9506), 219–224 (2006).
   PubMed Web of Science ®Google Scholar
• Dworkin RH, Backonja M, Rowbotham MC et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch. Neurol.60(11), 1524–1534 (2003).
   PubMed Web of Science ®Google Scholar
• Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain83(3), 389–400 (1999).
   PubMed Web of Science ®Google Scholar
• Sindrup SH, Otto M, Finnerup NB, Jensen TS. Antidepressants in the treatment of neuropathic pain. Basic Clin. Pharmacol. Toxicol.96(6), 399–409 (2005).
   PubMed Web of Science ®Google Scholar
• Baron R, Wasner G. Prevention and treatment of postherpetic neuralgia. Lancet367(9506), 186–188 (2006).
   PubMed Web of Science ®Google Scholar
• McQuay HJ, Tramer M, Nye BA, Carroll D, Wiffen PJ, Moore RA. A systematic review of antidepressants in neuropathic pain. Pain68(2–3), 217–227 (1996).
   PubMed Web of Science ®Google Scholar
• Raja SN, Haythornthwaite JA, Pappagallo M et al. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology59(7), 1015–1021 (2002).
   PubMed Web of Science ®Google Scholar
• Watson CP, Evans RJ, Reed K, Merskey H, Goldsmith L, Warsh J. Amitriptyline versus placebo in postherpetic neuralgia. Neurology32(6), 671–673 (1982).
   PubMed Web of Science ®Google Scholar
• Max MB, Schafer SC, Culnane M, Smoller B, Dubner R, Gracely RH. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology38(9), 1427–1432 (1988).
   PubMed Web of Science ®Google Scholar
• Watson CPN, Chipman M, Reed K. Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized double-blind, crossover trial. Pain23, 387–394 (1992).
   Google Scholar
• Watson CP, Vernich L, Chipman M, Reed K. Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology51(4), 1166–1171 (1998).
   PubMed Web of Science ®Google Scholar
• Graff-Radford SB, Shaw LR, Naliboff BN. Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia. Clin. J. Pain16(3), 188–192 (2000).
   PubMed Web of Science ®Google Scholar
• Rowbotham MC, Reisner LA, Davies PS, Fields HL. Treatment response in antidepressant-naive postherpetic neuralgia patients: double-blind, randomized trial. J. Pain6(11), 741–746 (2005).
   PubMed Web of Science ®Google Scholar
• Ray WA, Meredith S, Thapa PB, Hall K, Murray KT. Cyclic antidepressants and the risk of sudden cardiac death. Clin. Pharmacol. Ther.75(3), 234–241 (2004).
   PubMed Web of Science ®Google Scholar
• Sabatowski R, Galvez R, Cherry DA et al. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain109(1–2), 26–35 (2004).
   PubMed Web of Science ®Google Scholar
• Dworkin RH, Corbin AE, Young JP Jr et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology60(8), 1274–1283 (2003).
   PubMed Web of Science ®Google Scholar
• Freynhagen R, Strojek K, Griesing T, Whalen E, Balkenohl M. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain115(3), 254–263 (2005).
   PubMed Web of Science ®Google Scholar
• Oaklander AL, Buchbinder BR. Pregabalin-withdrawal encephalopathy and splenial edema: a link to high-altitude illness? Ann. Neurol.58(2), 309–312 (2005).
   PubMed Web of Science ®Google Scholar
• Bowsher D. The management of postherpetic neuralgia. Postgrad. Med. J.73(864), 623–629 (1997).
   PubMed Web of Science ®Google Scholar
• Boureau F, Legallicier P, Kabir-Ahmadi M. Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial. Pain104(1–2), 323–331 (2003).
   PubMed Web of Science ®Google Scholar
• Kalso E, Allan L, Dellemijn PL et al. Recommendations for using opioids in chronic non-cancer pain. Eur. J. Pain7(5), 381–386 (2003).
   PubMed Web of Science ®Google Scholar
• Rowbotham MC, Reisner-Keller LA, Fields HL. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology41(7), 1024–1028 (1991).
   PubMed Web of Science ®Google Scholar
• Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology50(6), 1837–1841 (1998).
   PubMed Web of Science ®Google Scholar
• Rowbotham MC, Twilling L, Davies PS, Reisner L, Taylor K, Mohr D. Oral opioid therapy for chronic peripheral and central neuropathic pain. N. Engl. J. Med.348(13), 1223–1232 (2003).
   PubMed Web of Science ®Google Scholar
• Edwards RR, Haythornthwaite JA, Tella P, Max MB, Raja S. Basal heat pain thresholds predict opioid analgesia in patients with postherpetic neuralgia. Anesthesiology104(6), 1243–1248 (2006)
   PubMed Web of Science ®Google Scholar
• Tella PK, Agarwal S, Klick B, Max MB, Haythornthwaite JA, Raja SN. Do the analgesic effects of opioids and tricyclic antidepressants differ in subtypes of patients with postherpetc neuralgia? In: Proceedings of the 11th World Congress on Pain. Flor H, Kalso E, Dostrosky JO (Eds). IASP Press, Seattle, WA, USA 487–493 (2006).
   Google Scholar
• Bernstein JE, Korman NJ, Bickers DR, Dahl MV, Millikan LE. Topical capsaicin treatment of chronic postherpetic neuralgia. J. Am. Acad. Dermatol.21(2 Pt 1), 265–270 (1989).
   PubMed Web of Science ®Google Scholar
• Watson CP, Tyler KL, Bickers DR, Millikan LE, Smith S, Coleman E. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin. Ther.15(3), 510–526 (1993).
   PubMed Web of Science ®Google Scholar
• Backonja M. High-concentration capsaicin for treatment of PHN and HIV neuropathy pain. Eur. J. Pain11(Suppl. 1), S40 (2007).
   Google Scholar
• Galer BS, Rowbotham MC, Perander J, Friedman E. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain80(3), 533–538 (1999).
   PubMed Web of Science ®Google Scholar
• Meier T, Wasner G, Faust M et al. Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study. Pain106(1–2), 151–158 (2003).
   PubMed Web of Science ®Google Scholar
• Rowbotham MC, Davies PS, Verkempinck C, Galer BS. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain65, 39–44 (1996).
   PubMed Web of Science ®Google Scholar
• Rowbotham MC, Davies PS, Fields HL. Topical lidocaine gel relieves postherpetic neuralgia. Ann. Neurol.37(2), 246–253 (1995).
   PubMed Web of Science ®Google Scholar
• Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin, or their combination for neuropathic pain. N. Engl. J. Med.352(13), 1324–1334 (2005).
   PubMed Web of Science ®Google Scholar
• Simpson DA. Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. J. Clin. Neuromusc. Dis.3, 53–62 (2001).
   PubMedGoogle Scholar
• Gillman PK. Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. Br. J. Anaesth.95(4), 434–441(2005).
   PubMed Web of Science ®Google Scholar
• Kochar DK, Garg P, Bumb RA et al. Divalproex sodium in the management of post-herpetic neuralgia: a randomized double-blind placebo-controlled study. QJM98(1), 29–34 (2005).
   PubMed Web of Science ®Google Scholar
• Kotani N, Kushikata T, Hashimoto H et al. Intrathecal methylprednisolone for intractable postherpetic neuralgia. N. Engl. J. Med.343(21), 1514–1519 (2000).
   PubMed Web of Science ®Google Scholar
• Nelson DA, Landau WM. Intrathecal methylprednisolone for postherpetic neuralgia. N. Engl. J. Med.344(13), 1019; author reply 1021–1012 (2001).
   PubMedGoogle Scholar
• Nelson KA, Park KM, Robinovitz E, Tsigos C, Max MB. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology48(5), 1212–1218 (1997).
   PubMed Web of Science ®Google Scholar
• Harke H, Gretenkort P, Ladleif HU, Koester P, Rahman S. Spinal cord stimulation in postherpetic neuralgia and in acute herpes zoster pain. Anesth. Analg.94(3), 694–700, (2002).
   PubMed Web of Science ®Google Scholar
• Haythornthwaite JA, Benrud-Larson LM. Psychological aspects of neuropathic pain. Clin. J. Pain16(Suppl. 2), S101–S105 (2000).
   PubMed Web of Science ®Google Scholar
• Haythornthwaite JA, Clark MR, Pappagallo M, Raja SN. Pain coping strategies play a role in the persistence of pain in post-herpetic neuralgia. Pain106(3), 453–460 (2003).
   PubMed Web of Science ®Google Scholar